<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Acta Naturae</journal-id><journal-title-group><journal-title xml:lang="en">Acta Naturae</journal-title><trans-title-group xml:lang="ru"><trans-title>Acta Naturae</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-8251</issn><publisher><publisher-name xml:lang="en">Acta Naturae Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10742</article-id><article-id pub-id-type="doi">10.32607/20758251-2009-1-3-6-9</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The Pharmaceutical Industry in Russia: Reality and Prospects</article-title><trans-title-group xml:lang="ru"><trans-title>The Pharmaceutical Industry in Russia: Reality and Prospects</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gordeev</surname><given-names>A I</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Fund «Open Economics»</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2009-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2009</year></pub-date><volume>1</volume><issue>3</issue><issue-title xml:lang="en">NO3 (2009)</issue-title><issue-title xml:lang="ru">№3 (2009)</issue-title><fpage>6</fpage><lpage>9</lpage><history><date date-type="received" iso-8601-date="2020-01-17"><day>17</day><month>01</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2009, Gordeev A.I.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2009, Gordeev A.I.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="en">Gordeev A.I.</copyright-holder><copyright-holder xml:lang="ru">Gordeev A.I.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://actanaturae.ru/2075-8251/article/view/10742">https://actanaturae.ru/2075-8251/article/view/10742</self-uri><abstract xml:lang="en"><p/></abstract><trans-abstract xml:lang="ru"><p>This section “Forum” is about the pharmaceutical industry in Russia. We were encouraged to debate this topic after the unveiling of the Strategy of Development of the Pharmaceutical Industry in the Russian Federation developed by the Ministry of Industry and Trade of the Russian Federation. The majority of our experts, who are authorities in the federal government, business, academia, and industrial science, believe that Russia needs a fully developed pharmaceutical industry. What are the main arguments for an intensive development of a Russian pharmaceutical industry- In our opinion, there are four major reasons.</p></trans-abstract></article-meta></front><body></body><back><ref-list/></back></article>
